Business
Currency:USD
2024/FY
Stock NameRevenueRatio
RECELL62.61M97.45%
Other wound care products1.05M1.64%
Lease revenue358K0.56%
Biomedical Advanced Research and Development Authority (BARDA) revenue for right of first access195K0.30%
Deferred commercial revenue recognized33K0.05%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States62.16M96.74%
Japan1.43M2.23%
Australia312K0.49%
United Kingdom196K0.31%
European Union155K0.24%